Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 434-850-2 | CAS number: 1680-31-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin irritation:
Key study:
The primary skin irritant effect of the test item was investigated in accordance with the OECD Guideline No. 404 and EU method B.4.Very slight skin reactions were observed among the rabbits. These reactions were not complete reversible in one animal 21 days after application of the test article.
Supporting study:
In this study the potential of the test item to induce skin irritations was assessed in vitro using the reconstructed human epidermal model EpiDermTM (EPI-200). The results obtained from the test indicated a mean viability greater than 50 after total 60 min incubation time and thus the test item is considered to be non-irritant.
Study results of skin irritation tests with humans (24 -h patch test) are reported in IUCLID section 7.10.5. The results revealed that the test item showed a good skin compatibility and did not lead to any skin reactions, thus, the test item is considered to be not irritating. Theses human data proved the results obtained from the animal studies.
Eye irritation:
Key study:
The eye irritation properties of the test item were evaluated using an in vivo test in accordance with OECD guideline 405 and EU method B.5. Slight signs of irritation were observed on the treated eyes, but these were not subject for classification.
Supporting study:
The eye irritation properties of the test item were evaluated using an in vitro HET-CAM test. According to this test, it is predicted that the test item does not cause strong eye irritation.
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
Skin irritation:
Key study:
The primary skin irritant effect of the test item was investigated in accordance with the OECD Guideline No. 404 and EU method B.4. Three female albino rabbits were exposed to the test article at two skin sites on the back. After 4 hours of exposure the test article was removed and the skin was examined 1, 24, 48 and 72 hours as well as 7, 14 and 21 days after termination of exposure. Very slight skin reactions were observed among the rabbits. The mean individual erythema scores were 0.17, 1.00, 1.00, respectively. The mean individual oedema scores were 0.00, 0.00, 0.33, respectively.These reactions were not complete reversible in one animal 21 days after application of the test article, but this was not subject for classification.
Supporting study:
The potential of the test item to induce skin irritations was assessed in vitro using the reconstructed human epidermal model EpiDermTM (EPI-200). The results obtained from the test indicated a mean viability greater than 50 after total 60 min incubation time and thus the test item is considered to be non-irritant.
Study results of skin irritation tests with humans (24 -h patch test) are reported in IUCLID section 7.10.5. The results revealed that the test item showed a good skin compatibility and did not lead to any skin reactions, thus, the test item is considered to be not irritating. Theses human data proved the results obtained from the animal studies.
Eye irritation:
Key study:
The eye irritation properties of the test item were evaluated using an in vivo test in accordance with OECD guideline 405 and EU method B.5. Three female albino rabbits were exposed to 0.1 mL of the test article in the left eye. The eyes were examined and the changes were graded according to a numerical scale one hour, 24, 48 and 72 hours after dosing. Slight signs of irritation were observed on the treated eyes. After 24 hours animal no. 1 and no. 2 showed some conjunctival vessels definitely injected. Some conjunctival vessels definitely injected and some swelling above normal was observed in animal no. 3. After 48 hours animal no. 1 showed some conjunctival vessels definitely injected. Animal no. 2 and no. 3 did not show any signs of eye irritation. After 72 hours all animals were free of any signs of eye irritation.
Supporting study:
The eye irritation properties of the test item was investigated in the in vitro HET-CAM test with incubated hen eggs. The HET-CAM Test is an alternative in vitro method for testing of severe eye/mucous membrane damage using the chorionallantoic membrane of fertilized, incubated hen eggs. Due to animal welfare reasons, the potential of severe irritation is determined in the HET-CAM in vitro system before deciding on a possible study in the rabbit as suggested in OECD Guideline 405.
The irritation potential of the undiluted test item is markedly lower than the irritation potential of the reference item Texapon ASV. Therefore the test item is considered to be not severly irritant.
Justification for classification or non-classification
Based on skin irritation data available, the test item is not classified as skin irritating according to Regulation No (EC) 1272/2008 (CLP) and Directive 67/548/EEC (DSD).
Based on eye irritation data available, the test item is not classified as eye irritating according to Regulation No (EC) 1272/2008 (CLP) and Directive 67/548/EEC (DSD).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.